Obi (Orlistat 60mg) Tabletsare a prescription medication used to aid the treatment of obesity. They come in a pack of four tablets, containing 120mg of Orlistat, which is the active ingredient orlistat. Obi is manufactured by Eli Lilly and the US market. Orlistat is a orlistat-x drug that is used to treat type 2 diabetes, high blood pressure, and certain cancers. It works by reducing the absorption of fat in the body, which leads to weight loss. This reduced fat absorption helps to reduce the risk of developing obesity-related health problems. Benefits of Obi Use Orlistat
Dosage and Administration
Obi tablets are usually taken once daily with a glass of water. It is important to follow the recommended dosage and administration instructions provided by your healthcare provider. It is not recommended for individuals with liver or kidney problems, as the medication may cause serious liver problems. Orlistat tablets are available in 120mg and 250mg strengths, making them a suitable choice for use in treating type 2 or 3 diabetes. It is also important to note that Orlistat should only be taken by adults and adolescents (17 years of age or older). It is recommended to use Orlistat with a meal to reduce the risk of stomach upset. It is also important to take the medication as directed by your healthcare provider, and to drink plenty of fluids to help retain it in the body. It is important not to skip any doses or stop the medication without consulting your doctor. It is important to continue taking Orlistat as prescribed and to complete the full course of treatment even if your symptoms improve, even if your doctor says you should. Side effects of Orlistat
We don't know which medication is best for you. If you've tried other weight loss medications and noticed that they don't work, let us know. Some commonly reported side effects of Orlistat include stomach upset, constipation, diarrhea, and nausea. If any of these persists or gets worse, let your doctor know. Orlistat may make you feel short of breath, dizziness, or fainting. It's important to speak to your healthcare provider if you're experiencing any of the following symptoms. It's possible that Orlistat may make you feel dehydrated. Avoid drinking too much alcohol while using this medication. If any of these effects persist or worsen, let your doctor know. It's important not to stop taking Orlistat without consulting your doctor, as they may adjust the dosage or recommend an alternative treatment. It's also important to note that Orlistat may increase the risk of developing liver problems. Therefore, it's important to discuss any concerns or questions you have with your doctor before starting Orlistat.
Key words:drugs, prescription, weight loss, weight loss drugs, prescription weight loss
This article is a summary of an article by, which was published by the New England Journal of Medicine on 1 February 2019.
The most commonly prescribed drug for weight loss is Xenical, the generic name for orlistat. Xenical is also sold as Xenical-Xenical orlistat-Xenical, as is all of the other popular weight loss medications that are sold under the names orlistat.
In fact, orlistat and Xenical are the two most common forms of weight loss medication sold under the names orlistat and Xenical, respectively.
This article discusses some of the most popular weight loss medications, how they work, and how they can be bought over the counter.
The drug class of medications for weight loss is called lipase inhibitors.
This article focuses on the Lipase inhibitors.
The Lipase inhibitors are oral lipase inhibitors (also called lipase inhibitors, or LIPIs), which are medications that contain an active ingredient that blocks the action of an enzyme called lipase. Lipase inhibitors work by preventing the lipase enzyme from breaking down the fat in food, thus helping your body absorb the fat more effectively.
As part of the Lipase inhibitors class, orlistat is marketed under the names orlistat-Xenical orlistat-Xenical, or as Xenical-Xenical orlistat-Xenical.
The drug class of drugs that are sold under the names orlistat and Xenical is called lipase inhibitors.
The drug class of medications that are sold under the names orlistat and Xenical is called lipase inhibitors.
If you’re new to weight loss treatments and want to learn more about them, we’re here to help.
Tablets like (the brand name for Orlistat) work by reducing the amount of fat your body absorbs. Ordinarily, fats are broken down during the digestion process by enzymes called lipases. Xenical prevents these enzymes from working effectively, limiting how much fat your body is able to absorb. The remaining, undigested fat is then excreted.
In contrast to Xenical, weight loss injections (or pens) work by suppressing your appetite - particularly your appetite for fatty foods. Some weight loss injections also slow the digestion process down, making you feel fuller for longer. They’re simple to use - check out our for more information.
Clinical trials have repeatedly demonstrated the effectiveness of both weight loss tablets and injections, particularly in combination with a healthy diet and lifestyle., participants using lost almost 15% of their body weight over a 15-month period.
Starting your weight loss journey is simple with IQ Doctor. To begin, click on a product and then hit the 'Start Consultation' button. The online consultation process is quick, simple and free; just complete the form and we’ll verify whether the medication is suitable for you or not. If it is, you can then place your order and receive it the very next day.
Send questionEthiopia
Select your chosen medication and complete the online consultation process as we highly recommend it. You’ll be able to ask more specific questions after you place your order.
Note:Our IQ Doctor questionnaire is for personal use only. It requires knowledge of the psychiatric, liver, and kidney condition. It doesn’t require medical advice or guidance from your doctor.
When making your treatment decision, if you choose to start with a healthy diet, limit your intake of sugars and non-alcoholic fatty meals. Consult your doctor before starting any medication. This will help ensure that your treatment is both effective and sustainable. You should also follow strict nutrition goals and incorporate additional fibre into your diet.
Additionally, take into account the following:
All these factors can affect your experience of the medication. When starting your weight loss journey, following the instructions and carefully considered before taking any medication can be beneficial. In addition, follow the recommended amounts of fibre and protein you are carrying into your diet. And don’t stop eating if you feel OK. Your body will adjust to the drug as you find new patterns in your diet.
In summary, before starting your weight loss journey, following the instructions and carefully considered before taking any medication can be beneficial:
If you’re uncomfortable with taking a medication, you should discuss your concerns with your healthcare provider. They can help determine if the chosen weight loss injection or tablet is suitable for you and monitor you regularly. They can also provide guidance on the correct dosage and potential side effects. Remember, your healthcare provider will be able to suggest an appropriate dose and potential risks if you have any. They can also advise on the best approach for your specific needs.
Share questionWarnings
As we’ve shown, the use of weight loss medications is not recommended without a healthy lifestyle. It’s essential to maintain a balanced diet and avoid fatty foods and sugars.
Also, consult your doctor before using any pharmaceutical product during your treatment. They can diagnose your specific needs and help you determine the most suitable weight loss medication for your needs.
Indications
Adults: Orlistat 120mg 120-80mg (120-80mg is the recommended starting dose in adults with a body mass index (BMI) of 30 or more kg/m2, weight-based treatment, usually with a reduced-calorie diet, physical activity and other dietary changes. If the patient has a BMI over 30 kg/m2, a reduced-calorie diet, regular physical activity and other non-dietary changes are not suitable, the dose may be increased and should be reduced.
Patients with severe obesity (BMI greater than 30 kg/m2) should have weight- and adipose tissue biopsy (X-ray or tissue biopsy) performed before initiating treatment with orlistat. The patient should have a normal physical examination, laboratory and medical history and have normal physical examinations and physical exercise and dietary advice before initiating treatment. If clinically appropriate for the indication, the patient should have a physical examination and/or laboratory report including laboratory values, body composition, blood pressure and heart rate.
Patients with mild to moderate hepatic impairment should have a reduced-calorie diet, regular physical activity and/or dietary changes. Patients with severely impaired hepatic function should have a normal-calorie diet and/or an appropriate treatment plan. Other interventions (e.g. nutritional support and therapy) may be required in severe hepatic impairment.
Patients with a BMI over 27 kg/m2 or severe hepatic impairment and the following conditions may benefit from reducing-calorie diet initiation:
In some patients with hepatic impairment, the dose of orlistat may be reduced to reduce the risk of gastrointestinal (colitis) and/or abdominal pain, e.g. in patients with chronic kidney disease or cirrhosis. In these cases, the patient should have a regular clinical and laboratory assessment and should be given appropriate advice and support.
Children and adolescents: The dose of orlistat in children is typically reduced to 120mg daily, whilst the dose may be increased to 80mg daily if the BMI is greater than 30kg/m2.
In the elderly, orlistat is usually recommended in patients with a body mass index (BMI) of 30kg/m2, weight-based treatment, usually with reduced-calorie diets and physical activity. In this patient group, the usual starting dose is 80mg daily.
In patients with hepatic impairment, orlistat is usually recommended in patients with severe hepatic impairment.